Back to search

National and Kapodistrian University of Athens

Κλινική αξιολόγηση των επιπέδων της β2 - μικροσφαιρίνης με ιδιοπαθή φλεγμονώδη νόσο του εντέρου

Abstract

dc:description

B2-Microglobulin (B2-M) is a low molecular weight protein not associated with the immunoglobulins. It is mainly produced by activated T-lymphocytes and macrophages in sites of immunoactivation of the above cells and in locations where acute inflammatory process takes place. B2- Microglobulin is not classified among acute phase proteins and its serum levels do not depend on the hepatic ability for synthesis and secretion. The aim of this study is the evaluation of B2-M serum levels as an index of T-lymphocytes and macrophages activation in patients suffering from ulcerative colitis (UC) and Crohn’s disease (CD), since immunoactivation reflects the degree of activity and severity of the inflammatory response. For this purpose B2-M was measured by an immunoenzymatic method in the serum of 87 patients with UC and 74 patients with CD. Based on widely accepted clinico-laboratory criteria 45% of patients with UC and 75% of patients with CD were classified as moderately or severely ill. The results are summarized and interpreted as follows: 1) in 35,6% of patients with UC abnormal serum levels of B2-M were detected. Fifty percent of patients with severe disease had elevated levels of serum B2-M whereas in 40% and 33% of those with moderate and mild disease abnormal levels were measured. Although the above results are indicative of the inflammatory response, these could lead to over-or underestimation regarding disease severity, 2) in 78,4% of patients suffering from CD raised levels of B2-M in the serum were detected. In the group of patients with severe disease 90,9% had elevated levels of B2-M. In the groups of patients with moderate and mild or quiescent disease the percentage was 84,8% and 52,6% accordingly. Moreover, regarding the location of the disease high percentages of abnormal B2-M serum levels were measured in patients with pancolitis (83,3%), in those with caecalileal involvement (84,6%) and finally in those where the disease affected the small bowel (86,3%). Based on recent data, constant immunoactivation of T-lymphocytes and macrophages in inflammation sites could explain all the above results. In conclusion this study shows that the evaluation of serum B2-M especially in patients with CD could become an additional diagnostic tool for the estimation of the inflammatory reaction, regarding early diagnosis and disease recurrence.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zissis, Miltiadis
  • Ζήσης, Μιλτιάδης

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20739

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zissis, Miltiadis; Ζήσης, Μιλτιάδης. Κλινική αξιολόγηση των επιπέδων της β2 - μικροσφαιρίνης με ιδιοπαθή φλεγμονώδη νόσο του εντέρου. National and Kapodistrian University of Athens, 2002. http://hdl.handle.net/10442/hedi/20739